Aksense Ltd is a private limited company located at The Hoxton Mix, 3Rd Floor, 86-90 Paul Street, London EC2A 4NE. Its net worth is estimated to be roughly 0 pounds, while the fixed assets that belong to the company total up to 0 pounds. Incorporated on 2019-03-20, this 5-year-old company is run by 1 director.
Director Asiye K., appointed on 20 March 2019.
The company is classified as "other human health activities" (Standard Industrial Classification code: 86900), "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110). According to official database there was a name change on 2019-07-25 and their previous name was Deepmicro Biomedical Ltd.
The latest confirmation statement was filed on 2022-10-25 and the due date for the next filing is 2023-11-08. Likewise, the statutory accounts were filed on 31 March 2022 and the next filing should be sent on 31 December 2023.
| Office Address | The Hoxton Mix |
| Office Address2 | 3rd Floor, 86-90 Paul Street |
| Town | London |
| Post code | EC2A 4NE |
| Country of origin | United Kingdom |
| Registration Number | 11892916 |
| Date of Incorporation | Wed, 20th Mar 2019 |
| Industry | Other human health activities |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st March |
| Company age | 5 years old |
| Account next due date | Sun, 31st Dec 2023 (138 days after) |
| Account last made up date | Thu, 31st Mar 2022 |
| Next confirmation statement due date | Wed, 8th Nov 2023 (2023-11-08) |
| Last confirmation statement dated | Tue, 25th Oct 2022 |
Position: Director
Appointed: 20 March 2019
The list of persons with significant control who own or control the company consists of 2 names. As BizStats researched, there is Asiye K. This PSC has 25-50% voting rights and has 25-50% shares. The second one in the persons with significant control register is Ersan A. This PSC owns 25-50% shares and has 25-50% voting rights.
Asiye K.
| Notified on | 20 March 2019 |
| Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
Ersan A.
| Notified on | 20 March 2019 |
| Ceased on | 6 September 2019 |
| Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
| Deepmicro Biomedical | July 25, 2019 |
| Agile Biomedical | March 23, 2019 |
| Profit & Loss | ||||
|---|---|---|---|---|
| Accounts Information Date | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
| Balance Sheet | ||||
| Current Assets | 200 | 157 | 5 | 4 |
| Net Assets Liabilities | 100 | 1 680 | 2 303 | 2 519 |
| Other | ||||
| Called Up Share Capital Not Paid Not Expressed As Current Asset | 100 | |||
| Creditors | 100 | 200 | 350 | 350 |
| Net Current Assets Liabilities | 200 | 43 | 345 | 346 |
| Number Shares Allotted | 100 | |||
| Par Value Share | 1 | |||
| Total Assets Less Current Liabilities | 200 | 43 | 345 | 346 |
| Type | Category | Free download | |
|---|---|---|---|
| CS01 |
Confirmation statement with no updates Wed, 25th Oct 2023 filed on: 2nd, December 2023 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy